Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Goldberg

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 3, 2010
Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteersJeng-Pyng Shaw, Jonathan Cheong, Michael R Goldberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2019
Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)Michael R Goldberg, Liat Nachshon, Michael B Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 1, 2024
Long-Term Outcome of IgE-Mediated Cow's Milk Allergy and Risk Factors for PersistenceLiat Nachshon, Michael R Goldberg, Naama Epstein-Rigbi, et al.
The Israel Medical Association Journal : IMAJ|May 26, 2012
Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergenMichael B Levy, Michael R Goldberg, Liat Nachshon, et al.
Research in Developmental Disabilities|December 9, 2008
Reliability and validity of the Vietnamese Vineland Adaptive Behavior Scales with preschool-age childrenMichael R Goldberg, Charles A Dill, Jin Y Shin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2018
Long-term outcome of peanut oral immunotherapy-Real-life experienceLiat Nachshon, Michael R Goldberg, Yitzhak Katz, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjectsShekman L Wong, Steven L Barriere, Michael M Kitt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 18, 2015
Oral immunotherapy in cow's milk allergic patients: course and long-term outcome according to asthma statusArnon Elizur, Michael R Goldberg, Michael B Levy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2013
Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow's milk allergyMichael B Levy, Arnon Elizur, Michael R Goldberg, et al.
The Israel Medical Association Journal : IMAJ|February 28, 2008
Cross-sensitization between milk proteins: reactivity to a "kosher" epitope?Yitzhak Katz, Michael R Goldberg, Galia Zadik-Mnuhin, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 3, 2010
Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteersJeng-Pyng Shaw, Jonathan Cheong, Michael R Goldberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2019
Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)Michael R Goldberg, Liat Nachshon, Michael B Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 1, 2024
Long-Term Outcome of IgE-Mediated Cow's Milk Allergy and Risk Factors for PersistenceLiat Nachshon, Michael R Goldberg, Naama Epstein-Rigbi, et al.
The Israel Medical Association Journal : IMAJ|May 26, 2012
Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergenMichael B Levy, Michael R Goldberg, Liat Nachshon, et al.
Research in Developmental Disabilities|December 9, 2008
Reliability and validity of the Vietnamese Vineland Adaptive Behavior Scales with preschool-age childrenMichael R Goldberg, Charles A Dill, Jin Y Shin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2018
Long-term outcome of peanut oral immunotherapy-Real-life experienceLiat Nachshon, Michael R Goldberg, Yitzhak Katz, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjectsShekman L Wong, Steven L Barriere, Michael M Kitt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 18, 2015
Oral immunotherapy in cow's milk allergic patients: course and long-term outcome according to asthma statusArnon Elizur, Michael R Goldberg, Michael B Levy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2013
Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow's milk allergyMichael B Levy, Arnon Elizur, Michael R Goldberg, et al.
The Israel Medical Association Journal : IMAJ|February 28, 2008
Cross-sensitization between milk proteins: reactivity to a "kosher" epitope?Yitzhak Katz, Michael R Goldberg, Galia Zadik-Mnuhin, et al.
Pageof 9